Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Duffull

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Clinical Pharmacology and Therapeutics|July 17, 2009
The effect of decontamination procedures on the pharmacokinetics of venlafaxine in overdoseV V P Kumar, S Oscarsson, L E Friberg, et al.
British Journal of Clinical Pharmacology|July 27, 1999
Paroxetine in human milkE J Begg, S B Duffull, D A Saunders, et al.
Clinical Pharmacology and Therapeutics|May 29, 2009
A population pharmacokinetic and pharmacodynamic evaluation of pralatrexate in patients with relapsed or refractory non-Hodgkin's or Hodgkin's lymphomaD R Mould, K Sweeney, S B Duffull, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Clinical Pharmacology and Therapeutics|July 17, 2009
The effect of decontamination procedures on the pharmacokinetics of venlafaxine in overdoseV V P Kumar, S Oscarsson, L E Friberg, et al.
British Journal of Clinical Pharmacology|July 27, 1999
Paroxetine in human milkE J Begg, S B Duffull, D A Saunders, et al.
Clinical Pharmacology and Therapeutics|May 29, 2009
A population pharmacokinetic and pharmacodynamic evaluation of pralatrexate in patients with relapsed or refractory non-Hodgkin's or Hodgkin's lymphomaD R Mould, K Sweeney, S B Duffull, et al.
Pageof 7